My first time at @myESMO meeting with some special people from @NCT_HD @koehlerlab @PaulaMorgane ❣️

Impressionen von der #DEGRO2024 @degro_ev Vortragssitzung: Re-Bestrahlung mit Lars B. Wessel zur Re-RT von Glioblastom-Rezidiven am Cyberknife! @UKHD_radonc @uniklinik_hd @Accuray

Meet the people behind #CCE - 📽️Check this insightful interview with Bruno Köhler from @NCT_HD, where he explains his experience with the #TRYTRAC Program and active member of CCE Education & Training pillar. Meet Bruno ➡️ https://t.co/UZPGlJICv0

NCT HD ist mit 2 FlashTalks beim #CCEAM24A des @CancerCoreEurope in Mailand: Bouchra Tawk berichtete über „Rationales for a Methylome Stratified Basket Trial in Locally Advanced Head & Neck Cancer” & Paula Hoffmeister-Wittmann über „Apoptotic signaling in gastrointestinal tumors”

Efficacy of morning versus afternoon aerobic #exercise training on reducing #metabolic syndrome components: A randomized controlled trial👇. #livertwitter #medtwitter #MAFLD

European Parliament Report on NCDs must be altered to protect EU Citizens from alcohol harms. We call on MEPs to REJECT: ☑️Compromise amendments under paragraph 3, paragraph 6 and under paragraph 7. ☑️BLOC VOTE 2 (Compromise Amend. 3,6,7 + recitals) 👉 https://t.co/vYiZJyg7vp

Oof. 😓 Burnout among oncologists has increased from 34% to 59% over the past 10 years. 22% likely to reduce clinical hours in the next year (up from 16%). #ASCOQLTY23

🔥 Atezolizumab + bevacizumab vs surveillance in resected or ablated high-risk HCC (IMbrave050) @TheLancet https://t.co/aGg24JqwYD 👉First positive adjuvant study in HCC 🧐Practice changing? 👉Don’t miss our commentary in @TheLancet @myESMO @EASLnews @ILCAnews #livertwitter

We're hiring! 🥳 We're currently looking for a motivated technician to join our young and dynamic team at @NCT_HD ! 🙌 Please feel free to share! - More positions for MD students also available - reach out! - https://t.co/iVzwVnI2l6

Nothing can justify striking a hospital. Nothing can justify targeting civilians. France condemns the attack on the Al-Ahli Arab hospital in Gaza, which made so many Palestinian victims. Our thoughts are with them. All the light must be shed on the circumstances.

Letzter Tag der #CCESumSchool2023 des @CancerCoreEU. In Albufeira, Portugal, kamen 69 Teilnehmer:innen und 31 Sprecher:innen aus ganz Europa und darüber hinaus zusammen – darunter 14 Vertreter:innen des NCT Heidelberg, @DKFZ und @uniklinik_hd .

Great week in Albufeira at @CancerCoreEU summer school with many thriving motivated young researchers from 35 different countries 🌍🎉 Loved everything about it!

Great end of the 1st day at our dkfz organoid summer school with a Keynote lecture by Xiling Shen about MOS as an innovative translational research tool 🧫🔬 @Xilis_Inc @jackstadt_lab @JensPuschhof @drbetge - Looking forward to tomorrow! 🤓

Hochpräzisions-Strahlentherapie Preis 2023! 🎉 @degro_ev Herzlichen Glückwunsch an Dr. Philipp Hoegen, Funktionsoberarzt @UKHD_radonc @uniklinik_hd für seine Arbeit zur C12-Radiotherapie bei HCC-Patienten. @NCT_HD #degro2023 #kassel

Fantastic event! “Summer School: #ORGANOIDS in next generation #cancer research” at Marsilius Kolleg @MKolleg, organized by researchers @DKFZ @uniklinik_hd @unimedizinma, co-funded by Health + Life Science Alliance #Heidelberg #Mannheim

Wir suchen zum nächstmöglichen Zeitpunkt Verstärkung für unser engagiertes Ärzte-Team der Klinik für Radioonkologie und Strahlentherapie des Universitätsklinikums Heidelberg! @UKHD_radonc Weiterbildungsassistent/in: https://t.co/ozNw2Y3M16 Facharzt/in: https://t.co/MOpzkt3b37

#LiverCancerSummit2023 is over and it has been a blast listening to many interesting talks and discussions as well as (re)connecting with motivated #LiverCancer researchers from all over the world! See you next year! 🔥👋🏼 @EASLedu @EASLnews

Happy to share our work on carbon ion radiation ☢️ for primary liver cancer showing excellent local control rates (2-y LCR 92.3%) and limited toxicities (1 case of > grade 2 AE) - prospective results of PROMETHEUS are about to be released shortly @UKHD_radonc @EASLedu @EASLnews

Inspiring talk by @ma5RN about when to discontinue first line treatment in #HCC as part of the first of 4 last sessions at day #3 at #LiverCancerSummit2023 with @LorenzaRimassa @TimGreten and many more 🎉

Nice session about locoregional therapies for #HCC with @ArndtVogel @IreneBargellini @ma5RN - still missing the radiooncological view of this topic ☝🏼 Hopefully this will change in the next few years! @EASLedu @EASLnews @UKHD_radonc #LiverCancerSummit2023